Table 2.
Multivariate analysis of variables on disease free survival and overall survival.
| Variable | Disease free survival |
Overall survival |
||
|---|---|---|---|---|
| p-Value | OR (95% CI) | p-Value | OR (95% CI) | |
| Age (<45 vs. 45 years) | 0.033 | 0.83 (0.90–2.50) | 0.041 | 0.50 (0.10–2.41) |
| Cormorbids (yes vs. no) | 0.091 | 1.28 (1.07–1.97) | 1.00 | 1.80 (0.79–2.10) |
| AJCC stage (<II vs. >II) | 0.041 | 0.67 (0.60–1.34) | 0.01 | 0.85 (0.80–1.90) |
| N stage (N0 vs. N1) | 0.033 | 0.81 (0.79–2.00) | 0.051 | 1.21 (1.10–2.10) |
| BMI kg/m2 (>30 vs. <30) | 0.052 | 1.15 (1.0–2.45) | 0.061 | 1.15 (1.01–1.65) |
| LVI (no vs. yes) | 0.031 | 0.91 (0.76–1.45) | 0.60 | 1.10 (0.89–2.00) |
| Adjuvant RAI (yes vs. no) | 0.031 | 0.50 (0.10–2.41) | 0.041 | 0.50 (0.67–2.81) |
OR, odds ratio; 95% CI, 95% confidence intervals; AJCC, American Joint Commission on Cancer; N, node; BMI, body mass index; LVI, lymphovascular invasion; RAI, radioactive iodine.